TRIDENT-1: A global, multicenter, open-label Phase II study investigating the activity of repotrectinib in advanced solid tumors harboring ROS1 or NTRK1-3 rearrangements Meeting Abstract
| Authors: | Doebele, R. C.; Lin, J. J.; Nagasaka, M.; Zhu, V. W.; Gabrail, N. Y.; Bazhenova, L.; Anderson, P. M.; Solomon, B. J.; Dudek, A. Z.; Pippas, A. W.; Shirinian, M.; Baik, C. S.; Stopatschinskaja, S.; Camidge, D. R.; Cho, B. C.; Drilon, A. E. |
| Abstract Title: | TRIDENT-1: A global, multicenter, open-label Phase II study investigating the activity of repotrectinib in advanced solid tumors harboring ROS1 or NTRK1-3 rearrangements |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368309257 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.TPS9637 |
| Notes: | Meeting Abstract: TPS9637 -- Source: Wos |
